374 related articles for article (PubMed ID: 31000384)
1. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
2. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
3. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
4. Repetitive enhancement of serum BDNF subsequent to continuation ECT.
Vanicek T; Kranz GS; Vyssoki B; Komorowski A; Fugger G; Höflich A; Micskei Z; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Acta Psychiatr Scand; 2019 Nov; 140(5):426-434. PubMed ID: 31369144
[TBL] [Abstract][Full Text] [Related]
5. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
[TBL] [Abstract][Full Text] [Related]
7. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
[TBL] [Abstract][Full Text] [Related]
8. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
10. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women.
Meyer JD; Koltyn KF; Stegner AJ; Kim JS; Cook DB
Psychoneuroendocrinology; 2016 Dec; 74():286-294. PubMed ID: 27697714
[TBL] [Abstract][Full Text] [Related]
11. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
Ryan KM; Dunne R; McLoughlin DM
Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
[TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
13. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
[TBL] [Abstract][Full Text] [Related]
14. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.
Bumb JM; Aksay SS; Janke C; Kranaster L; Geisel O; Gass P; Hellweg R; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):227-32. PubMed ID: 25231834
[TBL] [Abstract][Full Text] [Related]
15. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
16. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression.
Mikoteit T; Beck J; Eckert A; Hemmeter U; Brand S; Bischof R; Holsboer-Trachsler E; Delini-Stula A
Psychopharmacology (Berl); 2014 Aug; 231(15):2955-65. PubMed ID: 24562062
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
[TBL] [Abstract][Full Text] [Related]
18. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
19. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
20. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
